Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma. (Q52841091)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 October 2016

Language	Label	Description	Also known as
English	Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma.	scientific article published on 25 October 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

1 reference

based on heuristic

inferred from title

Andrei Thomas-Tikhonenko

9

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Stephan A Grupp

8

object named as

Stephan A Grupp

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

author name string

Hui Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Elena Sotillo

2

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Colleen Harrington

3

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Gerald Wertheim

4

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Michele Paessler

5

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Shannon L Maude

6

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Susan R Rheingold

7

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Vinodh Pillai

10

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

publication date

25 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

92

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

1

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

E11-E13

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

DNA repair genes are selectively mutated in diffuse large B cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity

1 reference

https://api.crossref.org/works/10.1002%2FAJH.24594

21 January 2018

Identifiers

10.1002/AJH.24594

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/27779774

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52841091&oldid=1572305392"